Supercentenarians have an abundance of cancer-killing immune cells
medicalxpress - The human immune system has specialized cells called CD4 cytotoxic T lymphocytes (CD4 CTLs), which have been shown to kill tumor cells in some cancers. When a person gets sick, these cells multiply in a process called clonal expansion to help fight infect…
AI Summary: Analyses of people over 110 reveal an abundance of highly active cytotoxic immune cells capable of recognizing and eliminating cancerous cells, offering clues to extreme longevity. These hypervigilant immune profiles may explain low cancer rates among the very old and suggest immune‑based strategies that could one day mimic their natural defenses.
Ex-Fauci adviser pleads guilty to plotting to conceal COVID-19 research records
abcnews - A former senior adviser to infectious disease expert Dr. Anthony Fauci has pleaded guilty to plotting to conceal federal records related to research on the origins of the deadly COVID-19 pandemic
AI Summary: A former scientific adviser to Dr. Fauci pleaded guilty to attempting to conceal COVID‑19 research records, admitting to actions to withhold or obscure documentation related to pandemic studies. The plea resolves part of a wider investigation into recordkeeping and transparency, and underscores legal exposure when internal scientific communications collide with public scrutiny.
Charles Roberts Named the Next President and CEO of St. Jude Children’s Research Hospital
oncodaily - Charles Roberts, Current Cancer Center Director and Executive Vice-President and Next President and CEO of St. Jude Children’s Research Hospital, shared St. Jude Children’s Research Hospital’s post on LinkedIn, adding: […]
AI Summary: Charles Roberts was named president and CEO of St. Jude Children’s Research Hospital, stepping into leadership of a globally recognized pediatric cancer and research institution. He’ll oversee strategy, fundraising and clinical priorities as the center pursues ambitious research and care goals — and deal with the inevitable complexity of running a world-class nonprofit hospital.
Senate Moves to Keep Politics Out of Cancer Research Funding
oncodaily - On August 2, 2026, US senators introduced a bipartisan temporary spending bill aimed at keeping the federal government funded. The bill also included a provision that would pause earlier proposed […]
AI Summary: Lawmakers advanced a bipartisan measure designed to delay a controversial OMB grantmaking rule and protect peer‑reviewed cancer research funding from politicized oversight. Scientific groups welcomed the move as a pragmatic step to preserve grant integrity and ensure researchers can continue work without sudden administrative disruptions.
- Clinical leaders defend peer review, oppose politicized funding (3)
- Inclusion and funding roles shaping cancer clinical research (3)
- Senate stalls OMB rule to shield cancer grants (3)
Clinical leaders defend peer review, oppose politicized funding
Inclusion and funding roles shaping cancer clinical research
Senate stalls OMB rule to shield cancer grants
Single dose of psilocybin for depression shows promising results in UK's first publicly funded randomized trial
medicalxpress - The first randomized controlled trial in the U.K. has found that a single dose of psilocybin, the active compound found in "magic mushrooms," produced significant improvements in depression compared with a placebo. This is the first publicly funded random…
AI Summary: A publicly funded randomized trial in the UK found that a single dose of psilocybin, delivered in a clinical setting, produced promising improvements for people with treatment-resistant major depressive disorder. The results suggest psychedelic-assisted therapy could be a viable addition to standard care—pending larger trials and careful safety monitoring—challenging old assumptions about one-and-done fixes.
This amino acid may help the body fight tumors and viral infections
medicalxpress - The amino acid arginine helps keep the human body humming, most notably by synthesizing proteins that carry out a range of cellular processes. It's produced by our bodies and found in common high-protein foods. Low levels of arginine are associated with a…
AI Summary: New research implicates the amino acid histidine in modulating immune and tumor biology, suggesting it may enhance anti-tumor responses and antiviral defenses in preclinical studies. Scientists report mechanistic insights that could inform future therapeutic strategies, although translation to patients will require careful testing—because promising mouse data still need to pass the human audit.
What We Know About Dr. Fauci Pleading the Fifth in Senate Hearing on Covid Origins
Sheryl Gay Stolberg and Benjamin Mueller / nytimes - In a three-hour Senate hearing this week, Dr. Fauci invoked his constitutional right to stay silent, leaving people confused about many of the issues raised.
AI Summary: A Senate hearing probing COVID-19’s origins put Dr. Anthony Fauci in the hot seat, with fierce questioning from senators including Rand Paul. At one point Fauci asserted his right against self-incrimination, sparking contentious exchanges, media analysis of his private notes and renewed debate about institutional decisions early in the pandemic.
- Plea of Fifth and Contempt Proceedings in Senate Probe (5)
- Private Notes, Cellphone Records and Political Fallout (3)
- Science, Media and Trust: Retractions and Expert Voices (3)
Plea of Fifth and Contempt Proceedings in Senate Probe
Private Notes, Cellphone Records and Political Fallout
Science, Media and Trust: Retractions and Expert Voices
HHS to stop funding ‘dangerous’ life sciences research
Paige Twenter / beckershospitalreview - The federal government will stop funding what it determines to be “dangerous” gain-of-function research conducted in the U.S. and abroad after implementing a new policy. The “Policy for Stopping High-Risk Life Sciences Research” lands during broader uphea…
AI Summary: The federal government announced a new policy curbing federal funding for defined categories of high‑risk life‑sciences research, citing biosafety and biosecurity concerns. The move pauses support for experiments judged to pose elevated pandemic or containment risks, sparking debate about how to balance oversight, scientific progress and public safety without stifling useful innovation.
Prediction Market Betting on Drug Trials and Approvals Sparks Concern About Undermining Research
Rebecca Robbins / nytimes - Prediction markets on Kalshi and Polymarket now let people wager money on drug approvals. Kalshi also plans to allow bets on clinical trial results.
AI Summary: Betting platforms have started offering markets on clinical trial outcomes and FDA decisions, stirring alarms among regulators and researchers. Critics warn these markets could incentivize insider trading, leak-sensitive information, or distort trial conduct, prompting calls for oversight and clearer rules to protect scientific integrity and participant safety — because apparently Wall Street needed another hobby.
It has begun: Foxconn amassing army of workers for iPhone 18 Pro assembly
appleinsider - Months ahead of the fall launches, and historically right on time, Apple supply chain partner Foxconn has started to hire a small army of assemblers to build the iPhone 18 Pro.Workers at a Foxconn facility - Image source: FoxconnEach summer, the Apple sup…
AI Summary: Agenus has suspended the BATTMAN clinical trial and announced a follow‑on program called ROBBIN after strategic reassessment, a move that has raised questions about transparency and participant communication. The abrupt pivot highlights tensions between rapid corporate decision‑making and the need to maintain patient trust in oncology research.
The AACR Rare Cancers Initiative: Uniting Researchers, Undoing Barriers, and Unleashing Progress
Steve Schneible / aacr - At the recent AACR Special Conference on Breaking Barriers in the Fight Against Rare Cancers, AACR Immediate Past President Lillian L. Siu, MD, FAACR, announced the AACR Rare Cancers Initiative. Learn more about how this new Initiative will marshal global…
AI Summary: The AACR has unveiled a Rare Cancers Initiative to coordinate researchers, streamline data sharing, and speed therapeutic development for uncommon tumor types. By pooling expertise, funding and networks, the program seeks to overcome the chronic scarcity of trials and resources that leave rare‑cancer patients waiting for attention that’s been hard to come by.
AHRQ terminates dozens of patient care research grants: Report
Elizabeth Gregerson / beckershospitalreview - HHS’ Agency for Healthcare Research and Quality has begun to terminate funding for research related to strengthening patient safety, care delivery, clinical practice and policy, and workforce training, according to a July 16 report from AcademyHealth. Aca…
AI Summary: The Agency for Healthcare Research and Quality has discontinued dozens of active research awards focused on patient care, citing programmatic changes and funding shifts. The abrupt terminations leave investigators scrambling and could slow progress on projects aimed at improving clinical practice and outcomes—proof that research pipelines are only as sturdy as their funding lines.
Could this enzyme help remove 'zombie' cells from our tissues?
medicalxpress - Our population is aging. The United Nations reports that by 2050, the number of people age 85 and older on our planet is set to triple. But a longer life span isn't the same as a longer health span (the number of years we spend healthy). Salk Institute sc…
AI Summary: Researchers identified an enzyme that selectively targets senescent “zombie” cells, restoring tissue function in preclinical models and hinting at anti‑aging and therapeutic possibilities. The findings generated excitement for potential disease‑modifying strategies, but experts caution that translating enzyme‑based fixes from mice to humans will require careful safety studies and sober expectations.
US actions harm global efforts to prevent and treat HIV in dozens of countries, new report says
medicalxpress - The Trump administration's disruptions to a global AIDS relief program have forced organizations to close clinics, lay off staff and cut services, seriously impeding efforts to prevent and treat the disease in dozens of countries, a new report released Tu…
AI Summary: A new analysis concludes recent U.S. policy shifts have weakened international HIV prevention and treatment initiatives, disrupting funding flows and partnership stability. Public health experts caution the changes could reverse progress in vulnerable regions, urging policymakers to recalibrate support to sustain global gains against HIV/AIDS.
Former Mayo Clinic Leader Sues System Over Alleged AI Cover-Up: 6 Things to Know
Katie Adams / medcitynews - A former Mayo Clinic research director claims she was silenced, demoted and ultimately fired for sounding the alarm on AI safety and patient privacy lapses at the health system. Traci Tamiko Eto is now suing Mayo for retaliation.The post Former Mayo Clini…
AI Summary: A former Mayo Clinic research director has filed suit alleging retaliation after raising concerns about the health system’s use and oversight of clinical AI. The complaint accuses leadership of suppressing warnings, sidelining the whistleblower and covering up problematic practices — seeking damages and reforms while triggering closer scrutiny of institutional AI governance.
- Clinical AI expansion, partnerships and industry pitfalls (5)
- Mayo whistleblower lawsuit alleges AI cover-up (3)
Clinical AI expansion, partnerships and industry pitfalls
Mayo whistleblower lawsuit alleges AI cover-up
American Cancer Society Reports Latest Global Cancer Statistics; Cancer Cases Approach 21 Million Worldwide, With Burden Projected to Surge 67% by 2050
cancer - New data reveal stark geographic inequities and call for urgent global action on prevention, early detection, and equitable treatment access
AI Summary: The American Cancer Society published updated global cancer statistics showing cases near 21 million and projecting a steep rise by midcentury, highlighting shifting incidence patterns and growing health system strain. The report calls for intensified prevention, screening and investment in equitable cancer control to blunt the projected surge.
- Cancer-type disparities: breast, GI, GU survival gaps (5)
- Global cancer estimates and headline numbers (6)
- WHO report launch and global call to action (5)
- All Other Stories
Cancer-type disparities: breast, GI, GU survival gaps
Global cancer estimates and headline numbers
WHO report launch and global call to action
All Other Stories
For the First Time, a Cell Built From Scratch Grows and Divides
Yasemin Saplakoglu / quantamagazine - Scientists built a synthetic cell that combines more lifelike properties than ever before — proof of concept that it’s possible to bring nonliving materials to life, or something close to it, in the lab. The post For the First Time, a Cell Built From Scra…
AI Summary: Scientists have for the first time built a synthetic cell from scratch that completes a full life cycle — growing and dividing in the lab. The milestone demonstrates control over core cellular processes, opening doors for bespoke biomanufacturing and disease modelling, while reviving familiar ethical and biosafety questions. Yes, it’s breathtaking — and yes, we should probably be cautious.
First use of precision editing to study human embryo development reveals role of master gene
medicalxpress - Research led by the University of Cambridge Loke Center for Trophoblast Research has shown that a genome-editing technique can be used to alter a single gene in human embryonic cells, enabling the study of very early human development in unparalleled deta…
AI Summary: Scientists used precision genome editing in human embryos to identify a 'master' developmental gene that triggers early human development stages. The finding clarifies key molecular steps, offering insights into congenital disorders and embryology, but also reignites ethical debate over experimental editing — cue the lab‑coat philosophers.
AACR Report on Cancer Disparities and Health Equity
oncodaily - American Association for Cancer Research (AACR) shared a post on LinkedIn: “The AACR Cancer Disparities Progress Report 2026 is now available. The report outlines the myriad factors that drive and […]
AI Summary: The American Association for Cancer Research released a progress report detailing persistent gaps in cancer outcomes across race, ethnicity, socioeconomic status and geography. It documents uneven access to screening, trials and treatments, calls for targeted funding, workforce diversity and policy fixes, and urges measurable equity goals—because apparently pointing out the problem is step one.
- AACR report release and leadership outreach (4)
- Policy push: briefings, funding calls, and trial equity (4)
AACR report release and leadership outreach
Policy push: briefings, funding calls, and trial equity
Congressional Budget Office calls for more research on No Surprises Act unintended impacts
fiercehealthcare - The nonpartisan office is seeking more information on the law’s impact on healthcare prices, network participation, ownership structures and more.
AI Summary: The Congressional Budget Office has called for additional research into the No Surprises Act, urging deeper study of the law’s unintended consequences on pricing, provider networks and patient costs. Federal agencies and stakeholders are being pressed to produce better evidence so policymakers can evaluate whether the law’s goals align with real-world effects.